May 28 |
Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn
|
May 28 |
Asahi Kasei offers to buy Calliditas Therapeutics for $1.1B
|
May 28 |
Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
|
May 28 |
Asahi Kasei Makes $1.1 Billion Bid For Swedish Calliditas Therapeutics
|
May 28 |
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
|
May 24 |
BJ's Wholesale Club To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday
|
May 23 |
Calliditas Therapeutics AB (publ) (CALT) Q1 2024 Earnings Call Transcript
|
May 23 |
Calliditas Therapeutics AB (publ) 2024 Q1 - Results - Earnings Call Presentation
|
May 23 |
Calliditas Q1 report, January - March 2024
|
May 16 |
In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action
|